Perceptive Advisors LLC Bei Gene, Ltd. Put Options Transaction History

Perceptive Advisors LLC

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2020 May 15, 2020	SELL	$121.84 - $173.19 $24.4 Million - $34.6 Million	-200,000 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$115.78 - $208.34 $23.2 Million - $41.7 Million	-200,000 Reduced 50.0%	200,000 $4,000
Q3 2019 Nov 14, 2019	BUY	$120.61 - $148.29 $48.2 Million - $59.3 Million	400,000 New	400,000 $2.7 Million

249

45.3M

292K

119K

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $20.1B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Perceptive Advisors LLC with notifications on news.